Analysts See $1.14 EPS for Medtronic plc (MDT)

November 10, 2018 - By Margaret Downey

Medtronic plc (NYSE:MDT) LogoInvestors sentiment decreased to 0.98 in Q2 2018. Its down 0.10, from 1.08 in 2018Q1. It fall, as 49 investors sold Medtronic plc shares while 436 reduced holdings. 99 funds opened positions while 374 raised stakes. 1.03 billion shares or 0.70% less from 1.04 billion shares in 2018Q1 were reported.
Piedmont Advsrs Limited Liability Co accumulated 0.24% or 58,817 shares. Palisade Asset Management owns 34,914 shares. California-based First Republic Mngmt Inc has invested 0.32% in Medtronic plc (NYSE:MDT). 10,420 are owned by Gould Asset Mgmt Ltd Liability Ca. The Arizona-based Dynamic Advisor Solutions Limited Com has invested 0.1% in Medtronic plc (NYSE:MDT). 30,805 were reported by Ironwood Counsel Ltd. Patten Group Incorporated Inc has invested 0.89% in Medtronic plc (NYSE:MDT). Compass Cap owns 3.96% invested in Medtronic plc (NYSE:MDT) for 317,714 shares. Oarsman Cap invested in 23,592 shares or 0.92% of the stock. 2,787 were reported by Oakworth Cap. American Century has invested 0.56% of its portfolio in Medtronic plc (NYSE:MDT). American Research And Mgmt has 100 shares for 0% of their portfolio. Frontier Inv Management holds 1.6% or 244,424 shares in its portfolio. New York-based F&V Capital Management Limited Liability Corporation has invested 3.22% in Medtronic plc (NYSE:MDT). Intact Invest Management reported 0.14% of its portfolio in Medtronic plc (NYSE:MDT).

Analysts expect Medtronic plc (NYSE:MDT) to report $1.14 EPS on November, 20.They anticipate $0.07 EPS change or 6.54 % from last quarter’s $1.07 EPS. MDT’s profit would be $1.54B giving it 20.69 P/E if the $1.14 EPS is correct. After having $1.17 EPS previously, Medtronic plc’s analysts see -2.56 % EPS growth. The stock decreased 0.40% or $0.38 during the last trading session, reaching $94.36. About 4.31M shares traded. Medtronic plc (NYSE:MDT) has risen 16.95% since November 10, 2017 and is uptrending. It has outperformed by 1.33% the S&P500.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 12 analysts covering Medtronic (NYSE:MDT), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Medtronic had 17 analyst reports since May 24, 2018 according to SRatingsIntel. Morgan Stanley maintained Medtronic plc (NYSE:MDT) rating on Friday, May 25. Morgan Stanley has “Equal-Weight” rating and $95 target. Needham upgraded Medtronic plc (NYSE:MDT) on Monday, August 13 to “Strong Buy” rating. The firm has “Buy” rating given on Friday, August 24 by Citigroup. Stifel Nicolaus maintained Medtronic plc (NYSE:MDT) rating on Wednesday, August 22. Stifel Nicolaus has “Hold” rating and $96 target. The rating was maintained by Bank of America with “Buy” on Thursday, May 24. As per Wednesday, August 22, the company rating was maintained by Bank of America. Argus Research maintained it with “Buy” rating and $120 target in Monday, October 8 report. The firm has “Buy” rating given on Wednesday, June 6 by Bank of America. Wells Fargo maintained Medtronic plc (NYSE:MDT) rating on Wednesday, August 22. Wells Fargo has “Market Perform” rating and $101 target. The company was maintained on Wednesday, August 22 by Morgan Stanley.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company has market cap of $127.43 billion. The company's Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It has a 40.69 P/E ratio. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

More news for Medtronic plc (NYSE:MDT) were recently published by: Globenewswire.com, which released: “Medtronic Delivers Significant Progress on Global Corporate Citizenship Efforts” on November 08, 2018. Globenewswire.com‘s article titled: “Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019” and published on November 09, 2018 is yet another important article.

Medtronic plc (NYSE:MDT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: